Search Results 711-720 of 15775 for 3-day reset protocol

  1. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid - Mayo Clinic

    Sponsor Protocol Number: R668-BP-1902. About this ... A minimum of 3 daily scores out of the 7 days is ... 3 times the upper limit of normal (ULN) during the ...

  2. Urology - Clinical trials

    ... three times daily. The study will occur over a 3 ... This Phase 3 study is designed to evaluate the ... This protocol is being designed to offer ...

  3. A Study of Hand Patterns in Children While Grasping Objects of Daily Use - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  4. Vascular centers - Clinical trials

    The purpose of this study is to validate the use of a lymphatic imaging protocol to stage disease severity in patients with lymphedema and serve as a biomarker ...

  5. Mayo Clinic

    Type 3 or more letters to display suggested search options. When ... Steve Day participated in a research study at Mayo Clinic to try to slow the ...

  6. Tobramycin (inhalation route) - Side effects & dosage - Mayo Clinic

    Always use a new Podhaler™ device every 7 days. To inhale this medicine, breathe out fully, trying to get as much air out of the lungs as possible. Put the ...

  7. Phase 3 Study Of Taletrectinib Vs Placebo As An Adjuvant Therapy In ROS1 Positive NSCLC (TRUST-IV) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

    3. During the early phases (phases 1 and 2) ... Sponsor Protocol Number: E5501-G000-310 ... Elective procedure performed prior to Visit 4 (Procedure Day) ...

  9. Health Topics - Mayo Clinic News Network

    What's National Wear Red Day? Deb Balzer. February 3, 2023 ... Mayo Clinic Minute: Congenital heart disease and pregnancy. Alex Osiadacz. February 3, 2023. World ...

  10. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    Sponsor Protocol Number: 2870-004. About this ... * Have an ECOG performance status of 0 or 1 within 3 days before randomization. ... 3 years. * Active ...